Azitra, Inc. (AZTR) vs Senti Biosciences, Inc. (SNTI)

Azitra, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Azitra, Inc. and Senti Biosciences, Inc. are of similar size ($10.1M and $10.0M). Senti Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 2.5×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −70.7%. Azitra, Inc. has the higher net margin (0.00% vs −3,789.3%) and the lower return on invested capital (−1,272.5% vs 0.00%). Across the 14 metrics below, Azitra, Inc. leads on 12 and Senti Biosciences, Inc. on 2.

Valuation

Metric AZTR SNTI Biotechnology median
P/E 2.54 n/m 7.88
P/S 5.66 7.86 11.47
P/B 0.45 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.31 n/m 0.74
EV/Sales (5.94) 2.94 10.73
Earnings yield 39.35% (536.36%) (28.84%)
Free cash flow yield (346.99%) (369.11%) (23.03%)

Profitability

Metric AZTR SNTI Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (4,181.12%) 0.00%
Net margin 0.00% (3,789.30%) 0.00%
Free cash flow margin 0.00% (2,900.38%) 0.00%
Return on equity (256.67%) (466.46%) (57.72%)
Return on assets (190.69%) (97.52%) (49.22%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR SNTI Biotechnology median
Revenue growth (TTM) 58.18% (70.73%) 5.64%
EPS growth (last fiscal year) 85.67% 77.31% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric AZTR SNTI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 0.83 4.73
Net debt to EBITDA 0.20 0.25 0.96

Dividend

Metric AZTR SNTI Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric AZTR SNTI Biotechnology median
Market cap 10.10m 9.96m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack